Navigation Links
The In View series hosted by Larry King Announces plans for a series on Autoimmune Diseases
Date:2/8/2013

Boca Raton, FL (PRWEB) February 08, 2013

The producers of the In View TV series, an educational TV series hosted by Larry King, have announced plans to focus on autoimmune diseases and the push to cure them in an upcoming series. These diseases, which have no cure and often have nebulous causes, afflict tens of millions of Americans, affecting their health and quality of life. Diseases that come under this classification include type-I diabetes, multiple sclerosis and rheumatoid arthritis. The In View Larry King show, which runs on cable outlets across the country, will inform TV audiences about some of the many autoimmune diseases, in which the body’s immune system attacks and destroys healthy tissues and cells, as well as efforts to cure these diseases and develop better treatments for them. The Larry King TV show will spotlight researchers as well as companies across the country working to develop cures and treatments.

In November, researchers at the National Institute of Biomedical Imaging and Bioengineering announced a possible breakthrough in the treatment of autoimmune diseases. The institute’s approach involved re-educating the body’s T-cells to not attack healthy tissue. This series of the In View with Larry King show (http://www.inviewseries.com) will look at advances such as this and more, giving rare attention to diseases and patients that often get overlooked. The In View TV series (855-446-8439) will showcase organizations and companies that have made progress in the fight against various autoimmune disorders and diseases.

The Larry King In View show (561-544-7965) offers enlightening episodes and series on many important and timely subjects throughout American culture. It features veteran television personality Larry King, the long-time host of “Larry King Live” on CNN.

Read the full story at http://www.prweb.com/releases/in-view-with-larry-king/autoimmune-diseases/prweb10413646.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
2. DuPont Pioneer Launches Next Generation T Series Soybeans
3. Management Matters Series Starts with “Lab Budgeting 101”
4. QSI Announces RS Series of Deep Cooled CCD Cameras
5. Cieri Media Announces New Science Series 'Bright Ideas' Focusing on Latest Inventions
6. Rudy Mazzocchi Prepares to Release the Second Thriller in The EQUITY Series Trilogy, entitled EQUITY of FEAR
7. The Veterinary Bioscience Institute Announces an Amazing Series of 41 Webinars for 2013
8. BioTechniques Announces the Publication of 'Transfection' – The First Issue of a New, Digital-Only Spotlight Series
9. Avelas Biosciences Closes $7.65 Million Series A, Advances Real-Time Tumor Visualization Technology Toward Development
10. Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
11. Advanced Cell Diagnostics Completes $12 Million Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Md. , June 23, 2016 A person ... from the crime scene to track the criminal down. ... the U.S. Food and Drug Administration (FDA) uses DNA evidence ... Sound far-fetched? It,s not. The FDA ... sequencing to support investigations of foodborne illnesses. Put as simply ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
(Date:6/23/2016)... ... , ... In a new case report published today in STEM CELLS Translational ... lymphedema after being treated for breast cancer benefitted from an injection of stem cells ... this debilitating, frequent side effect of cancer treatment. , Lymphedema refers to ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
(Date:6/20/2016)... Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring announced that after ... secured the final acceptance by all three (3) ... Systems (MAS) installed. Furthermore, Securus will have contracts ... by October, 2016. MAS distinguishes between legitimate wireless ...
(Date:6/9/2016)... , June 9, 2016 ... Police deploy Teleste,s video security solution to ensure the safety ... France during the major tournament Teleste, ... communications systems and services, announced today that its video security ... to back up public safety across the country. ...
Breaking Biology News(10 mins):